|
Volumn 130, Issue 2, 2009, Pages 200-201
|
Acute viral hepatitis as a confounding factor in patients with antituberculosis treatment induced hepatotoxicity
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
ISONIAZID;
PHENYTOIN;
PYRAZINAMIDE;
RIFAMPICIN;
TUBERCULOSTATIC AGENT;
ADULT;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ALKALINE PHOSPHATASE BLOOD LEVEL;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
BILIRUBIN BLOOD LEVEL;
CAUSAL ATTRIBUTION;
DIAGNOSTIC ACCURACY;
DIFFERENTIAL DIAGNOSIS;
DISEASE CLASSIFICATION;
DISEASE MANAGEMENT;
EXTRAPULMONARY TUBERCULOSIS;
FEMALE;
HEPATITIS A;
HEPATITIS B;
HEPATITIS E;
HEPATITIS VIRUS;
HUMAN;
LETTER;
LIVER FUNCTION;
LUNG TUBERCULOSIS;
MAJOR CLINICAL STUDY;
MALE;
MILIARY TUBERCULOSIS;
RISK FACTOR;
TOXIC HEPATITIS;
TUBERCULOSIS;
VIRUS HEPATITIS;
ADULT;
ANTITUBERCULAR AGENTS;
HEPATITIS, VIRAL, HUMAN;
HUMANS;
LIVER;
MALE;
MIDDLE AGED;
TUBERCULOSIS;
YOUNG ADULT;
|
EID: 70349548606
PISSN: 09715916
EISSN: 09715916
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (8)
|
References (6)
|